17Α-METHYLTESTOSTERONE (ANABOLIC ANDROGENIC STEROIDS) ALTERS ACETYLCHOLINESTERASE ENZYME ACTIVITY IN DIFFERENT PARTS OF THE BRAIN IN FEMALE MICE, MUS MUSCULUS
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i5.24736Keywords:
Anabolic-androgenic steroids, Acetylcholinesterase, Forebrain, Hippocampus, Midbrain, HindbrainAbstract
Aim: Anabolic androgenic steroids (AAS) are synthetic derivatives of the male sex hormone testosterone. Androgens and anabolic steroids have been used for therapeutic purpose with few exceptions. However, the abuse of AAS is a remarkably prevalent problem, particularly among athletes and adolescents. Supraphysiological doses of AAS exert profound effects on mental state and behaviors such as depression, anxiety, aggressiveness, and cognitive deterioration.
Objective: In the present investigation, we studied the impact of one of the AAS compounds, i.e., 17α-methyltestosterone on acetylcholinesterase (AChE) enzyme activity in different brain parts of mice, namely, forebrain, hippocampus, midbrain, and hindbrain.
Methods: The adult female mice were assigned to four experimental groups to which different doses of 17α-MT (0.5, 5.0 and 7.5 mg/kg bwt, respectively) were administrated s.c. for 30 days. A significant increase in AChE activity in forebrain and midbrain (low and medium dose treatment) suggests a reduction of cholinergic neurotransmission efficiency due to decrease in acetylcholine levels in trans-synaptic cleft. Further, concurrent reduction in AChE activity was observed in whole brain, hippocampus, and hindbrain of 17α-MT-treated mice suggests the impairment in neuronal transmission. Since the regulation of cholinergic system through acetylcholine hydrolysis has been largely attributed to AChE activity, a significant reduction in its activity may lead to stress-related anxiety, memory loss with some cognitive and behavioral aspects in the mice.
Conclusion: Based on the observed results, we propose that 17α-MT, an alkylated steroid compound, has a negative impact on AChE enzyme activity in different parts of mice brain, leading to impairment in neuronal transmission.
Downloads
References
Kochakian CD. Anabolic androgenic steroid: A historical perspective and definitions. In: Yesalis CE, editor. Anabolic Steroids in Sports and Exercise. Champaign, IL: Human Kinetics Publishers, Inc; 1993. p. 3-33.
Basaria S, Wahlstrom JT, Dobs AS. Clinical review 130: Anabolic androgenic steroid therapy in the treatment of chronic diseases. J Clin Endocrinol Metab 2001;86:5108-17.
Shahidi NT. A review of the chemistry, biological action and clinical applications of anabolic- androgenic steroid. Clin Ther 2001;23:1355-90.
Kicman AT. Pharmacology of anabolic steroids. Br J Pharmacol 2008;154:502-21.
Nieschlag E, Vorona E. Mechanisms in endocrinology Medical consequences of doping with anabolic androgenic steroids: Effects on reproductive functions. Eur J Endocrinol 2015;173:47-8.
Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med 2004;34:513-54.
NIDA. Research Report-Steroid Abuse and Addiction: NIH Publication No. 00-3721. Bethesda, MD: National Institute on Drug Abuse (NIDA); 2000.
Iriart JA, Andrade TM. Body-building, steroid use, and risk perception among young body-builders from a low-income neighborhood in the city of Salvador, Bahia State, Brazil. Cad Saude Publ 2002;18:1379-87.
Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the future national survey results on drug use, 1975-2012. Secondary School Students. Vol. I. Ann Arbor: Institute for Social Research, the University of Michigan; 2013. p. 604.
Inamdar Doddamani LS, Jayamma Y. Acceleration of neutrophil precursors’ maturation and immunostimulation of CD3+, CD4+ lymphocytes by stanozolol in mice. J Steroid Biochem Mol Biol 2012;129:172-8.
McEwen BS, Biegon A, Davis PG, Krey LC, Luine VN, McGinnis MY, et al. Steroid hormones: Humoral signals which alter brain cell properties and functions. Rec Prog Horm Res 1982;38:41-2.
Giacobini E, Pepeu G, editors. The Brain Cholinergic System in Health and Disease. Abingdon [England]: Informa Healthcare; 2006.
Silver A. The biology of Cholinesterases. The Netherlands: North- Holland; 1974.
Herlenius E, Lagercrantz H. Development of neurotransmitter systems during critical periods. Exp Neurol 2004;190:8-21.
Thiblin I, Kristiansson M, Rajs J. Anabolic androgenic steroids and behavioural patterns among violent offenders. J Forensic Psychiatry 1997;8:299-10.
Hall RC, Hall RC, Chapman MJ. Psychiatric complications of anabolic steroid abuse. Psychosomatics 2005;46:285-90.
Papazisis G, Kouvelas D, Mastrogianni A, Karastergiou A. Anabolic androgenic steroid abuse and mood disorder: A case report. Int J Neuropsychopharmacol 2007;10:291-3.
Trenton AJ, Currier GW. Behavioural manifestations of anabolic steroid use. CNS Drugs 2005;19:571-95.
Kaufman MJ, Janes AC, Hudson JI, Brennan BP, Kanayama G, Kerrigan AR, et al. Brain and cognition abnormalities in long-term anabolic-androgenic steroid users. Drug Alcohol Depend 2015;152:47-6.
Strauss RH, Yesalis CE. Additional effects of anabolic steroids on women. In: Yesalis CE, editor. Anabolic Steroids in Sports and Exercise. Champaign, IL: Human Kinetics Publishers Inc.; 1993. p. 151-60.
Ellman GL, Courtney KD, Andres V Jr, Featherstone RM. A new and rapid colorimetric determination of acetyl cholinesterase activity. Biochem Pharmacol 1961;7:88-95.
Gorun V, Proinov I, Baltescu V, Balaban G, Barzu O. Modified Ellman procedure for assay of cholinesterases in crude enzymatic preparations. Anal Biochem 1978;8:324-6.
Jameson RR, Seidler FJ, Slotkin TA. Nonenzymatic functions of acetylcholinesterase splice variants in the developmental neurotoxicity of organophosphates: Chlorpyrifos, chlorpyrifos oxon, and diazinon. Environ Health Perspect 2007;115:65-70.
Martins DB, Mazzanti CM, Spanevello R, Schmatz R, Cargnelutti JF, Schmidt C, et al. Subchronic administration of nandrolone decanoate in acetylcholinesterase activity in wistar rats. Comp Clin Pathol 2012;21:256-68.
Pieretti S, Mastriota M, Tucci P, Battaglia G, Trabace L, Nicoletti F, et al. Brain nerve growth factor unbalance induced by anabolic androgenic steroids in rats. Med Sci Sports Exe 2013;45:29-5.
Tanehkar F, Rashidy-Pour A, Vafaei AA, Sameni HR, Haghigh S, Miladi-Gorji H, et al. Voluntary exercise does not ameliorate spatial learning and memory deficits induced by chronic administration of nandrolone decanoate in rats. Horm Behav 2013;63:158-65.
Rainer Q, Speziali S, Rubino T, Dominguez-Lopez S, Bambico FR, Gobbi G, et al. Chronic nandrolone decanoate exposure during adolescence affects emotional behavior and monoaminergic neurotransmission in adulthood. Neuropharmacology 2014;83:79-8.
Kaufer D, Friedman A, Seidman S, Soreq H. Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 1998;393:373-7.
Singh A, Jatav VK, Sharma S. Virtual screening and admet analysis for identification of inhibitors against acetylcholin esterase associated with Alzheimer’s disease. Int J Pharm Pharm Sci 2014;6:155-9.
Patil SB, Inamdar Doddamani LS. Stanozolol induces alterations in antioxidant cascade and AChE activity in brain and renal function in female mice, Mus musculus. Am J Pharm Health Res 2017;5:89-904.
Soreq H, Seidman S. Acetylcholinesterase-new roles for an old actor. Nat Rev Neurosci 2001;2:294-302.
Tougu V, Kesvatera T. Role of ionic interactions in cholinesterase catalysis. Biochim Biophys Acta 1996;1298:12-30.
Mineur YS, Obayemi A, Wigestrand MB, Fote GM, Calarco CA, Li AM, et al. Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior. PNAS 2013;110:3573-8.
Saricicek A, Esterlis I, Maloney KH, Mineur YS, Ruf BM, Muralidharan A, et al. MRCPsych. Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder. Am J Psychiatry 2012;169:851-9.
Bueno A, Carvalho FB, Gutierres JM, Lhamas C, Andrad CM. A comparative study of the effect of the dose and exposure duration of anabolic androgenic steroids on behavior, cholinergic regulation, and oxidative stress in rats. PLoS One 2017;12:e0177623.
Abreu-Villaca Y, Filgueiras CC, Manhaes AC. Developmental aspects of the cholinergic system. Behav Brain Res 2011;221:367-78.
Oberlander JG, Poeter DM, Penatti CA, Henderson LP. Anabolic androgenic steroid abuse: Multiple regulation GABAergic synapses in neuroendocrine control regions of rodent forebrain. J Neuroendocrinol 2012;24:202-14.
Tugyan K, Ozbal S, Cliaker S, Kiray M, Pekcetin C, Ergur BU, et al. Neuroprotective effect of erythropoietin on nandrolone decanote induced brain injury in rats. Neurosci Lett 2013;533:28-33.
Estrada M, Varshney A, Ehrlich BE. Elevated testosterone induces apoptosis in neuronal cells. J Biol Chem 2006;281:25492-501.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
